? e-coli ?
https://www.google.com/search?q=antibacterial+resistant+bacteria+e-coli+from+human+feces&rlz=1C1CHZN_enNZ947NZ947&ei=PFSwZOmjA8XV1e8Px_ausAw&ved=0ahUKEwjpscWKuYyAAxXFavUHHUe7C8YQ4dUDCBA&uact=5&oq=antibacterial+resistant+bacteria+e-coli+from+human+feces&gs_lcp=Cgxnd3Mtd2l6LXNlcnAQAzIFCAAQogQyBQgAEKIEMgUIABCiBDIFCAAQogQyBQgAEKIEOgoIABBHENYEELADSgQIQRgAUJRgWOF4YLl8aANwAHgAgAHWAYgBjgaSAQUwLjIuMpgBAKABAcABAcgBCA&sclient=gws-wiz-serp
https://www.pharmaceutical-technology.com/uncategorized/recce-327-recce-pharmaceuticals-escherichia-coli-infections-likelihood-of-approval/
.
- Forums
- ASX - By Stock
- RCE
- Ann: First Cohort Dosed in Rapid Infusion Phase I/II UTI study
Ann: First Cohort Dosed in Rapid Infusion Phase I/II UTI study, page-16
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
|
|||||
Last
46.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $102.0M |
Open | High | Low | Value | Volume |
46.0¢ | 46.5¢ | 46.0¢ | $145.6K | 316.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 82151 | 46.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
46.5¢ | 57606 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 82151 | 0.460 |
5 | 160708 | 0.455 |
11 | 209394 | 0.450 |
3 | 142000 | 0.445 |
5 | 127820 | 0.440 |
Price($) | Vol. | No. |
---|---|---|
0.465 | 56800 | 1 |
0.480 | 8360 | 2 |
0.485 | 95000 | 1 |
0.495 | 110000 | 2 |
0.500 | 60000 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |